Bright Path Laboratories Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bright Path Laboratories's estimated annual revenue is currently $4.4M per year.(i)
  • Bright Path Laboratories's estimated revenue per employee is $201,000

Employee Data

  • Bright Path Laboratories has 22 Employees.(i)
  • Bright Path Laboratories grew their employee count by -39% last year.

Bright Path Laboratories's People

NameTitleEmail/Phone
1
CEO Reveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Director AnalyticsReveal Email/Phone
4
Senior Director Talent AcquisitionReveal Email/Phone
5
Director, Patient Advocacy and Public AffairsReveal Email/Phone
6
Accounts Payable ManagerReveal Email/Phone
7
Office ManagerReveal Email/Phone
8
Regulatory Affairs and Strategic Initiatives AdvisorReveal Email/Phone
9
Environmental Health and Safety SupervisorReveal Email/Phone
10
Documentation Specialist/TrackWise AdministratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is Bright Path Laboratories?

An agile and patented advanced pharmaceutical manufacturing technology paving the way for rapid, low-cost and scalable domestic API production. Bright Path Labs (BPL) is positioned to immediately fill gaps in the drug supply chain in response to the COVID-19 pandemic; including the agile manufacturing of hydroxychloroquine (HCQ), and other potential treatments or subsequently discovered vaccines and medicines to address future health challenges. We have the physical and technical capacity for the agile research and development of advanced pharmaceutical manufacturing that is scalable, that helps us train a future workforce for research and is able to support Federal agencies to rapidly address drug shortages.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$4.4M

Revenue (est)

-39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M27-16%$1.8M
#2
$4.3M28-18%N/A
#3
$2.7M33-8%N/A
#4
$7.5M39-2%N/A
#5
$1.7M418%N/A